Condition
Mechanical Circulatory Support clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Mechanical Circulatory Support clinical trials that are recruiting, at sites in 39 countries (most in Austria (3), France (2), Argentina (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 39Countries
Newest Mechanical Circulatory Support clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Optimizing Impella 5.5 Outcomes With Advanced Data Science | — | Vienna | Recruiting | Jun 1, 2026 |
| Outcomes in patients with mixed cardiogenic and vasoplegic shock | — | Amiens, Somme | Recruiting | Jan 21, 2026 |
| Supira System in high-risk PCI: a pivotal comparison to Impella | — | Loma Linda, California and 25 other locations | Recruiting | Dec 22, 2025 |
| Personalized stem cell therapy for heart failure patients with LVAD support | Phase 2 | Ljubljana | Recruiting | Dec 1, 2023 |
| Noninvasive monitoring of heart function in patients with LVADs | — | Vienna | Recruiting | Nov 23, 2020 |
| Registry for evaluating Medtronic products | — | Birmingham, Alabama and 401 other locations | Recruiting | Feb 1, 2012 |
All recruiting trials (6)
-
Optimizing Impella 5.5 Outcomes With Advanced Data Science
This study tests whether real-world data from Impella 5.5 patients with cardiogenic shock can help predict heart recovery and prevent complications, using advanced data science.
-
Outcomes in patients with mixed cardiogenic and vasoplegic shock
This registry will try to describe outcomes and risk factors in adults admitted with cardiogenic shock who also have inappropriate vasodilation (mixed cardiogenic‑vasoplegic shock).
-
Supira System in high-risk PCI: a pivotal comparison to Impella
This study tests whether the Supira System can safely and effectively support the heart during high-risk PCI, compared with the currently available Impella device.
-
Personalized stem cell therapy for heart failure patients with LVAD support
This study is testing a personalized stem cell treatment for heart failure patients who are getting a heart pump to see if it helps their heart recover better after surgery.
-
Noninvasive monitoring of heart function in patients with LVADs
This study is testing new ways to monitor heart function in people with a HeartMate 3 LVAD to see if they can get better information than the usual methods like echocardiograms and ECGs.
-
Registry for evaluating Medtronic products
This study is collecting information to see how safe and effective Medtronic products are for patients who are using them.
Related topics
Quick answers
How many Mechanical Circulatory Support clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 39 countries. The most sites are in Austria (3 trials), France (2 trials), Argentina (1 trial), Australia (1 trial), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.